One of the Belmont Report's most important contributions was the clear and serviceable distinction it drew between standard medical practice and biomedical research. A less well-known achievement of the Report was its conceptualization of innovative practice, a type of medical practice that is often mistaken for research because it is new, untested, or experimental. Although the discussion of innovative practice in Belmont is brief and somewhat cryptic, this does not reflect the significant progress its authors made in understanding innovative practice and the distinctive ethical issues it raises. This article explores the history and broader context of Belmont's conception of innovative practice, its strengths and weaknesses, and its contemporary relevance for scholars working in bioethics and health policy. While this conception of innovative practice deserves our attention, it is inherently limited in some important ways.

中文翻译：

---

贝尔蒙特报告和创新实践

贝尔蒙特报告最重要的贡献之一是它在标准医疗实践和生物医学研究之间做出了明确而有用的区分。该报告的一个鲜为人知的成就是其对创新实践的概念化，这是一种经常被误认为是研究的医学实践，因为它是新的、未经测试的或实验性的。尽管贝尔蒙特对创新实践的讨论简短且有些含糊，但这并不能反映其作者在理解创新实践及其引发的独特伦理问题方面取得的重大进展。本文探讨了贝尔蒙特创新实践概念的历史和更广泛的背景、其优势和劣势，以及它与从事生物伦理学和卫生政策工作的学者的当代相关性。